loadpatents
name:-0.01268196105957
name:-0.0052309036254883
name:-0.0015230178833008
Universitat Zurich Prorektorat MNW Patent Filings

Universitat Zurich Prorektorat MNW

Patent Applications and Registrations

Patent applications and USPTO patent grants for Universitat Zurich Prorektorat MNW.The latest application filed is for "means and methods for identifying a patient having a braf-positive cancer as a non-responder to a braf inhibitor as a responder ".

Company Profile
1.4.11
  • Universitat Zurich Prorektorat MNW - Zurich CH
  • Universitat Zurich Prorektorat MNW -
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Means and methods for identifying a patient having a BRAF-positive cancer as a non-responder to a BRAF inhibitor as a responder
App 20190194757 - Levesque; Mitchell Paul ;   et al.
2019-06-27
APC-mediated tolerance induction for therapy of multiple sclerosis
Grant 9,592,259 - Dresch , et al. March 14, 2
2017-03-14
N-(1-cyano-2-hydroxy-1-methyl-ethyl)-4-(trifluoromethylsulfanyl)benzamide Derivatives For Use As Nematocidal Drugs
App 20160368868 - ANSELL; Brendan Robert ;   et al.
2016-12-22
Biological Heart Valve Replacement, Particularly For Pediatric Patients, And Manufacturing Method
App 20160220361 - Weber; Benedikt ;   et al.
2016-08-04
Bispecific Her2 Ligands For Cancer Therapy
App 20150284463 - Tamaskovic; Rastislav ;   et al.
2015-10-08
Device for Repair Surgery of Cylindrical Organs, Particularly Ruptured Tendons
App 20140324078 - Buschmann; Johanna
2014-10-30
Adjustable virtual reality system
Grant 8,868,373 - Eng , et al. October 21, 2
2014-10-21
Apc-mediated Tolerance Induction For Therapy Of Multiple Sclerosis
App 20140242037 - Dresch; Christiane ;   et al.
2014-08-28
Modulators of miR-323-3p for the Prevention or Treatment of Rheumatoid Arthritis
App 20140193366 - Gay; Steffen ;   et al.
2014-07-10
Methods of treating sickle cell anemia-related conditions with MK-801 or memantine
Grant 8,680,042 - Bogdanova , et al. March 25, 2
2014-03-25
Treatment of scleroderma
Grant 8,247,389 - Gay , et al. August 21, 2
2012-08-21
Treatment Of Scleroderma
App 20110218233 - Gay; Steffen ;   et al.
2011-09-08
Adjustable Virtual Reality System
App 20110202306 - Eng; Kynan ;   et al.
2011-08-18
Blockers Of Serotonin And Its Receptors For The Treatment Of Hepatitis
App 20100255001 - Lang; Karl ;   et al.
2010-10-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed